BioLife Solutions Inc
NASDAQ:BLFS
Intrinsic Value
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. [ Read More ]
The intrinsic value of one BLFS stock under the Base Case scenario is 9.46 USD. Compared to the current market price of 18.46 USD, BioLife Solutions Inc is Overvalued by 49%.
Valuation Backtest
BioLife Solutions Inc
Run backtest to discover the historical profit from buying and selling BLFS stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
BioLife Solutions Inc
Current Assets | 120.6m |
Cash & Short-Term Investments | 35.4m |
Receivables | 18.7m |
Other Current Assets | 66.5m |
Non-Current Assets | 292.1m |
Long-Term Investments | 5.1m |
PP&E | 40.3m |
Intangibles | 245.9m |
Other Non-Current Assets | 821k |
Current Liabilities | 42.2m |
Accounts Payable | 6.9m |
Accrued Liabilities | 19.5m |
Other Current Liabilities | 15.7m |
Non-Current Liabilities | 32.9m |
Long-Term Debt | 19.5m |
Other Non-Current Liabilities | 13.4m |
Earnings Waterfall
BioLife Solutions Inc
Revenue
|
143.3m
USD
|
Cost of Revenue
|
-96.5m
USD
|
Gross Profit
|
46.8m
USD
|
Operating Expenses
|
-102.1m
USD
|
Operating Income
|
-55.3m
USD
|
Other Expenses
|
-11.1m
USD
|
Net Income
|
-66.4m
USD
|
Free Cash Flow Analysis
BioLife Solutions Inc
What is Free Cash Flow?
BLFS Profitability Score
Profitability Due Diligence
BioLife Solutions Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
BioLife Solutions Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
BLFS Solvency Score
Solvency Due Diligence
BioLife Solutions Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
BioLife Solutions Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BLFS Price Targets Summary
BioLife Solutions Inc
According to Wall Street analysts, the average 1-year price target for BLFS is 23.75 USD with a low forecast of 20.2 USD and a high forecast of 31.5 USD.
Ownership
BLFS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
BLFS Price
BioLife Solutions Inc
Average Annual Return | 21.18% |
Standard Deviation of Annual Returns | 93.08% |
Max Drawdown | -85% |
Market Capitalization | 833.8m USD |
Shares Outstanding | 45 300 000 |
Percentage of Shares Shorted | 10.94% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. The company is headquartered in Bothell, Washington and currently employs 432 full-time employees. Its products are used in basic and applied research and commercial manufacturing of biologic-based therapies. The company has a portfolio of tools and services that focus on biopreservation, cell processing, frozen biologic storage products and services, cold-chain transportation, and thawing of biologic materials. Its tools portfolio includes its CryoStor and HypoThermosol biopreservation media for shipping and storage, the ThawSTAR family of automated, water-free thawing products, evo cold chain management system, high capacity cryogenic storage freezers, Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools. Customers use its products to maintain the health and function of biologic material during sourcing, manufacturing, storage, and distribution.
Contact
IPO
Employees
Officers
The intrinsic value of one BLFS stock under the Base Case scenario is 9.46 USD.
Compared to the current market price of 18.46 USD, BioLife Solutions Inc is Overvalued by 49%.